The state venture capital fund led an add-on investment for Columbia’s Healthcare Interactive and is the kind of deal the fund wants to do more of in the future.
It’s abundantly clear that microörganisms play an essential role in maintaining the health of humans, animals, and plants. But how exactly they pull this off is still mostly a mystery—one that the White House hopes to help solve by way of a new microbiome research initiative.
Funding and Research Opportunities
The following funding opportunity announcements from the NHLBI or other components of the National Institutes of Health, might be of interest:
Notices:
- Notice of Intent to Publish a Funding Opportunity Announcement for Human Heredity and Health in Africa (H3Africa): Ethical, Legal, and Societal Issues (ELSI) Research Program (U01)
- (NOT-RM-16-014)
- NIH Roadmap Initiatives
- Notice of Intent to Publish a Funding Opportunity Announcement for Human Heredity and Health in Africa (H3Africa): Ethical, Legal, and Societal Issues (ELSI) Collaborative Centers (U54)
- (NOT-RM-16-015)
- NIH Roadmap Initiatives
- Notice of Intent to Publish a Funding Opportunity Announcement for Human Heredity and Health in Africa (H3Africa): Research Grants (U01)
- (NOT-RM-16-016)
- NIH Roadmap Initiatives
- Notice of Intent to Publish a Funding Opportunity Announcement for Human Heredity and Health in Africa (H3Africa): Collaborative Centers (U54)
- (NOT-RM-16-017)
- NIH Roadmap Initiatives
- Notice of Intent to Publish a Funding Opportunity Announcement for Human Heredity and Health in Africa (H3Africa): Administrative Coordinating Center (U24)
- (NOT-RM-16-018)
- NIH Roadmap Initiatives
- Notice of Intent to Publish a Funding Opportunity Announcement for Human Heredity and Health in Africa (H3Africa): Informatics Network (U24)
- (NOT-RM-16-019)
- NIH Roadmap Initiatives
- BD2K Predoctoral Training in Biomedical Big Data Science (T32)
- (RFA-LM-16-002)
- National Library of Medicine, National Center for Advancing Translational Sciences, National Center for Complementary and Integrative Health, National Cancer Institute, National Eye Institute, National Human Genome Research Institute, National Heart, Lung, and Blood Institute
- Dissemination and Implementation Research in Health (R01)
- (PAR-16-238)
- National Cancer Institute, National Center for Complementary and Integrative Health, National Human Genome Research Institute, National Heart, Lung, and Blood Institute
Due to California’s penchant for legislating at the ballot box, the state has reigned as the top destination for industry campaign spending since even before the Supreme Court widened the door to corporate political donations with its 2010 Citizens United decision.
Europe already has many of the ingredients for successful biotech and pharma activity—top-tier academic research, a commitment to public research funding, a heritage of pharmaceutical giants stretching back to 1668 (when Merck was founded in Darmstadt, Germany), and a growing number of biotechs nurtured by regional biotech clusters (especially in Germany and France).
This week at Health Datapalooza, a group of medtech and pharma companies traded insights on the strategic partnerships they built with technology companies and what they learned in the process. But they also touched on how they collaborate with startups.
Johns Hopkins University took over the No. 1 spot on this week’s List of patents in Maryland. The private research institution obtained 133 patents in 2015, achieving a total of 454 patents in the last five years.
It would be easy to mistake the Universities at Shady Grove as a flagship public school, with its red-brick buildings and its state-of-the-art labs, library and fitness center.
Stafford County leaders voted to infuse $500,000 into the county’s Tech and Research Park.
The money from the county’s Economic Opportunity Fund will be used to launch a co-working space and business incubator at the Quantico Corporate Center site in North Stafford. Incubators attract start-up companies and entrepreneurs looking for temporary office and meeting space to grow their firms.
Not only have several of the top bioscience companies in our region grown in the past year, but we can already predict some of the biggest growth spurts we’ll see next.